|
Volumn 76, Issue 1, 2013, Pages 49-56
|
Towards a tailored therapy in pancreatic cancer.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
CHEMOKINE RECEPTOR CXCR4;
CXCR4 PROTEIN, HUMAN;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
TUMOR MARKER;
ADENOCARCINOMA;
ARTICLE;
DRUG ANTAGONISM;
HUMAN;
METABOLISM;
METHODOLOGY;
PANCREAS CARCINOMA;
PANCREAS TUMOR;
PERSONALIZED MEDICINE;
ADENOCARCINOMA;
ANTIMETABOLITES, ANTINEOPLASTIC;
CARCINOMA, PANCREATIC DUCTAL;
DEOXYCYTIDINE;
HUMANS;
INDIVIDUALIZED MEDICINE;
PANCREATIC NEOPLASMS;
RECEPTORS, CXCR4;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 84879144276
PISSN: 00015644
EISSN: None
Source Type: None
DOI: None Document Type: Article |
Times cited : (9)
|
References (0)
|